POLARISqb will revolutionize drug design by joining Quantum Computing with AI and Precision Medicine. Our platform will produce up to 100 drug blueprints per year. We will compress the lead time for preclinical drug candidates from 5 years to 4 months, enabling real time adaptability to the precision medicine market. POLARISqb will own an IP portfolio of drug assets to license, sell, or develop internally.
No products posted yet
No services posted yet
This data is part of our proprietary analytics report:
This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality